BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsai YC, Chiu YW, Kuo HT, Lee JJ, Lee SC, Chen TH, Lin MY, Hwang SJ, Kuo MC, Hsu YL, Chen HC. The interaction between fluid status and angiopoietin-2 in adverse renal outcomes of chronic kidney disease. PLoS One 2017;12:e0173906. [PMID: 28333979 DOI: 10.1371/journal.pone.0173906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Dekker MJE, van der Sande FM, van den Berghe F, Leunissen KML, Kooman JP. Fluid Overload and Inflammation Axis. Blood Purif 2018;45:159-65. [PMID: 29478061 DOI: 10.1159/000485153] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
2 Shirali AS, Lluri G, Guihard PJ, Conrad MB, Kim H, Pawlikowska L, Boström KI, Iruela-Arispe ML, Aboulhosn JA. Angiopoietin-2 predicts morbidity in adults with Fontan physiology. Sci Rep 2019;9:18328. [PMID: 31797976 DOI: 10.1038/s41598-019-54776-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
3 He F, Zhang D, Chen Q, Zhao Y, Wu L, Li Z, Zhang C, Jiang Z, Wang Y. Angiopoietin‐Tie signaling in kidney diseases: an updated review. FEBS Lett 2019;593:2706-15. [DOI: 10.1002/1873-3468.13568] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Lee KH, Moon I, Oh YS, Yu BC, Park MY, Kim JK, Choi SJ. Prediction of Heart Function and Volume Status in End-Stage Kidney Disease Patients through N-Terminal Pro-Brain Natriuretic Peptide. Medicina 2022;58:975. [DOI: 10.3390/medicina58080975] [Reference Citation Analysis]
5 Kooman JP, van der Sande FM. Body Fluids in End-Stage Renal Disease: Statics and Dynamics. Blood Purif 2019;47:223-9. [PMID: 30517920 DOI: 10.1159/000494583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]